Intravenous Infusions Limited announced earnings results for the year ended December 31, 2015. For the year, the company's revenue was GHC 7,529,883 compared to GHC 6,464,964 a year ago. Operating profit was GHC 134,786 compared to operating loss of GHC 472,546 a year ago.

Net loss before tax was GHC 555,166 compared to GHC 985,170 a year ago. Total comprehensive loss was GHC 519,638 compared to GHC 776,803 a year ago. Net cash used in operating activities was GHC 1,787,581 compared to net cash from operating activities of GHC 254,238 a year ago.

Purchase of property, plant and equipment was GHC 56,907 compared to GHC 302,037 a year ago.